Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup

It took several years of investor pressure to oust Bayer CEO Werner Baumann. Last week the company revealed former Roche pharma chief Bill Anderson would replace Baumann, a year before his hitch was up.

Investors have started to speculate that under Anderson’s leadership, Bayer will be more open to follow an industry trend by separating its three business sectors—pharma, consumer health and crop science. It’s a move that Baumann held out against late in his tenure.